NeuropeptidesCompanion animal
Canine cognitive dysfunction as a model for human age-related cognitive decline, dementia and Alzheimer's disease: clinical presentation, cognitive testing, pathology and response to 1-deprenyl therapy
Ruehl WW, Bruyette DS, DePaoli A, et al. · Prog Brain Res · 1995
PMID: 8584657 · DOI: 10.1016/s0079-6123(08)61960-6
Summary
Veterinary characterization of canine cognitive dysfunction as a translational dementia model, with cognitive testing battery and response to 1-deprenyl. Endpoints: clinical signs, neuropathology, behavioral scores.
Citation hosted by NCBI. We link to the source so the researcher can read the abstract, full text, or references-cited list directly.
More Neuropeptides citations
- Efficacy and Safety of Cerebrolysin for Acute Ischemic Stroke: A Meta-Analysis of Randomized Controlled TrialsNeurol Sci · 2018
- Cerebrolysin in patients with acute ischemic stroke in Asia: results of a double-blind, placebo-controlled randomized trialStroke · 2012
- Efficacy and possible mechanisms of action of a new peptide anxiolytic selank in the therapy of generalized anxiety disorders and neurastheniaZh Nevrol Psikhiatr Im S S Korsakova · 2007